*Current Perspectives on Viral Disease Outbreaks - Epidemiology, Detection and Control*

them acceptable to the researchers. All the more, the commercially available mimics and inhibitors of the miRNAs makes the research pertaining to them affordable. However, miRNAs face the challenges of specific, on-site delivery, long-term miRNA stability and off-target consequences, and yet, have been FDA-approved under the small molecule therapeutics category. The challenges of targeted delivery and optimum bioavailability is met with the miRNA-loaded nanoparticles, which diminish the off-target effects as well. Thus, with miRNAs finding their utility into a variety of applications, expansion of the miRNA investigations, both in basic and applied research, is evident.
